Programmed Death Ligand 1 (PDL1) Expression in Neoadjuvant Triple-Negative Breast Cancer: Association With Chemotherapy Response and Residual Cancer Burden [0.03%]
新辅助治疗后三阴性乳腺癌程序死亡配体1(PD-L1)表达与化疗疗效及残留病灶负荷的关系研究
Atif Ali Hashmi,Noreen Wahid,Ghazala Mudassir et al.
Atif Ali Hashmi et al.
Background: Programmed death ligand 1 (PDL1) expression in tumors is linked to immune evasion in various cancers, making these patients potential candidates for PDL1 inhibitors. Although immune checkpoint blockade therapy...
Nicole Nelson,Jennifer Den,Roi Weiser et al.
Nicole Nelson et al.
Background: Clips placed after core needle biopsy are often several millimeters to centimeters from the biopsy cavity. Radiofrequency and radar (R) localization involve a second localization procedure based on the prior clip placement, pote...
Life Postdiagnosis: Female Adult Breast Cancer Survivors' Experience With Physical Activity-A Qualitative Systematic Review [0.03%]
确诊后的生活状况：女性成人乳腺癌幸存者进行身体活动的经验-定性系统评价
Neeve Brown,Fiona Muirhead
Neeve Brown
Background: With increasing survival rates of breast cancer, there is a need for more research to understand the experiences of survivors. Previous quantitative studies have shown that physical activity can be beneficial for breast cancer s...
Skin Involvement of Idiopathic Granulomatous Mastitis: Sonographic, Clinical, and Histopathological Features [0.03%]
原发性肉芽肿性乳腺炎的皮肤受累：超声、临床及病理特征分析
Fatih Işık,Erdal Pala,Fatih Alper et al.
Fatih Işık et al.
Objectives: Idiopathic granulomatous mastitis (IGM) is a rare benign breast disease in which cutaneous involvement is insufficiently characterized. This study aimed to evaluate the sonographic, clinical, and histopathological features of sk...
Corrigendum to "Primary bilateral breast lymphoma in an elder male patient" [0.03%]
“老年男性患者双侧乳腺原发性淋巴瘤”一文的勘误通知
[This corrects the article DOI: 10.1111/tbj.13394.]. Copyright © 2025 The Breast Journal published by John Wiley & Sons Ltd.
Published Erratum
The breast journal. 2025 Sep 19:2025:9821303. DOI:10.1155/tbj/9821303 2025
Corrigendum to "Analysis of Conventional Ultrasound and Contrast-Enhanced Ultrasound Features of Pseudoangiomatous Stromal Hyperplasia" [0.03%]
伪血管性基质增生的常规超声和造影超声特征分析的勘误通知书
[This corrects the article DOI: 10.1155/tbj/6070736.]. Copyright © 2025 The Breast Journal published by John Wiley & Sons Ltd.
Published Erratum
The breast journal. 2025 Sep 19:2025:9801706. DOI:10.1155/tbj/9801706 2025
Corrigendum to "The Quest for Outpatient Mastectomy in COVID-19 Era: Barriers and Facilitators" [0.03%]
“探求COVID-19时代乳腺癌日间手术的障碍与促进因素”一文勘误
[This corrects the article DOI: 10.1155/2022/1863519.]. Copyright © 2025 The Breast Journal published by John Wiley & Sons Ltd.
Published Erratum
The breast journal. 2025 Sep 15:2025:9847254. DOI:10.1155/tbj/9847254 2025
Morphological Assessment of Breast Lesions With Type 2 Dynamic Curves Using DWI and T2WI Based on Breast Imaging Reporting and Data System Lexicon Descriptors [0.03%]
基于乳腺影像报告和数据系统词汇描述的DWI和T2WI对乳腺二期动态曲线病变的形态学评估
Liying Zhang,Gongsheng Zhu,Kefan Wang et al.
Liying Zhang et al.
Purpose: This study aimed to qualitatively assess the added diagnostic value of diffusion-weighted imaging (DWI) and T2-weighted imaging (T2WI), using Breast Imaging Reporting and Data System (BI-RADS) lexicon descriptors, in evaluating bre...
Applicability of Oncotype DX Testing in a Diverse Breast Cancer Population in Hawaii [0.03%]
夏威夷多样化的乳腺癌人群中Oncotype DX检测的应用性研究
Kyle Xia,Eileen Chen,Roxana Hu et al.
Kyle Xia et al.
Purpose: The Oncotype DX test is standardly used for patients with early-stage, hormone-receptor-positive, HER2-negative breast cancers to determine the benefit from chemotherapy and the likelihood of distant recurrence. The relationship be...
Real-World Efficacy of HLX02-Based Neoadjuvant Therapy in HER2-Positive Breast Cancer: Clinical Insights and Future Directions [0.03%]
基于国产曲妥珠单抗新辅助治疗HER2阳性乳腺癌的疗效分析及临床展望
Zhengzhi Zhu,Jing Wang,Shikai Hong et al.
Zhengzhi Zhu et al.
Background: The efficacy of HLX02, a trastuzumab biosimilar, in combination with chemotherapy for treating metastatic breast cancer (BC) has been established as equivalent to the reference Herceptin. This study aimed to assess the treatment...